Literature DB >> 24768815

ILDR1: Novel mutation and a rare cause of congenital deafness in the Saudi Arabian population.

Khushnooda Ramzan1, Khalid Taibah2, Asma I Tahir3, Nada Al-Tassan3, Amal Berhan3, Ahmed M Khater2, Selwa A F Al-Hazzaa4, Mohammed Al-Owain5, Faiqa Imtiaz3.   

Abstract

Hearing impairment is the common human sensorineural disorder and is a genetically heterogeneous phenotype for which more than 100 genomic loci have been mapped so far. ILDR1 located on chromosome 3q13.33, encodes a putative transmembrane receptor containing an immunoglobulin-like domain. We used a combination of autozygosity mapping and candidate gene sequencing to identify a novel mutation in ILDR1, as a causative gene for autosomal-recessive non-syndromic hearing loss (arNSHL) in a consanguineous Saudi family with three affected children. Autozygosity mapping identified a shared region between the affected individuals encompassing ILDR1 on chromosome 3q13.12-3q22.1. Sequencing revealed homozygous 9 base pair duplication, resulting in an in-frame duplication of three amino acids p.(Asn109_Pro111dup). The mutation was segregating with the disease phenotype and is predicted to be pathogenic by SIFT and PROVEAN. The identified mutation is located in the immunoglobulin-type domain of the ILDR1 protein. In silico analysis using I-TASSER server and PyMOL offers the first predictions on the structural and functional consequences of this mutation. To our knowledge, this is the first ILDR1 mutation identified in a Saudi family. Identification of ILDR1 mutation in only one of 100 Saudi familial and sporadic individuals with hearing loss suggests that this mutation is unique to this family and that ILDR1 should be considered as a rare cause of congenital deafness among Saudi Arabian population. Our data also confirms the evidence for ILDR1 allelic heterogeneity and expands the number of familial arNSHL-associated ILDR1 gene mutations.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Autozygosity; Deafness; ILDR1; Protein structure prediction; PyMOL; Saudi Arabia

Mesh:

Substances:

Year:  2014        PMID: 24768815     DOI: 10.1016/j.ejmg.2014.04.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

1.  Two novel mutations in ILDR1 gene cause autosomal recessive nonsyndromic hearing loss in consanguineous Iranian families.

Authors:  Zohreh Mehrjoo; Mojgan Babanejad; Kimia Kahrizi; Hossein Najmabadi
Journal:  J Genet       Date:  2015-09       Impact factor: 1.166

2.  Downsloping high-frequency hearing loss due to inner ear tricellular tight junction disruption by a novel ILDR1 mutation in the Ig-like domain.

Authors:  Nayoung K D Kim; Tomohito Higashi; Kyoung Yeul Lee; Ah Reum Kim; Shin-ichiro Kitajiri; Min Young Kim; Mun Young Chang; Veronica Kim; Seung-Ha Oh; Dongsup Kim; Mikio Furuse; Woong-Yang Park; Byung Yoon Choi
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

3.  Discovering the Unexpected with the Utilization of NGS in Diagnostics of Non-syndromic Hearing Loss Disorders: The Family Case of ILDR1-Dependent Hearing Loss Disorder.

Authors:  Jernej Kovač; Gašper Klančar; Katarina Trebušak Podkrajšek; Saba Battelino
Journal:  Front Genet       Date:  2017-06-30       Impact factor: 4.599

4.  A Novel p.G141R Mutation in ILDR1 Leads to Recessive Nonsyndromic Deafness DFNB42 in Two Chinese Han Families.

Authors:  Xueling Wang; Longhao Wang; Hu Peng; Tao Yang; Hao Wu
Journal:  Neural Plast       Date:  2018-04-16       Impact factor: 3.599

5.  Identification of a novel frameshift mutation in the ILDR1 gene in a UAE family, mutations review and phenotype genotype correlation.

Authors:  Abdelaziz Tlili; Abdullah Fahd Al Mutery; Mona Mahfood; Walaa Kamal Eddine Ahmad Mohamed; Khalid Bajou
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

6.  Genome-wide association meta-analysis identifies five novel loci for age-related hearing impairment.

Authors:  Andries Paul Nagtegaal; Linda Broer; Nuno R Zilhao; Johanna Jakobsdottir; Charles E Bishop; Marco Brumat; Mark W Christiansen; Massimiliano Cocca; Yan Gao; Nancy L Heard-Costa; Daniel S Evans; Nathan Pankratz; Sheila R Pratt; T Ryan Price; Christopher Spankovich; Mary R Stimson; Karen Valle; Dragana Vuckovic; Helena Wells; Gudny Eiriksdottir; Erik Fransen; Mohammad Arfan Ikram; Chuang-Ming Li; W T Longstreth; Claire Steves; Guy Van Camp; Adolfo Correa; Karen J Cruickshanks; Paolo Gasparini; Giorgia Girotto; Robert C Kaplan; Michael Nalls; John M Schweinfurth; Sudha Seshadri; Nona Sotoodehnia; Gregory J Tranah; André G Uitterlinden; James G Wilson; Vilmundur Gudnason; Howard J Hoffman; Frances M K Williams; André Goedegebure
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

7.  Identification of Novel CDH23 Variants Causing Moderate to Profound Progressive Nonsyndromic Hearing Loss.

Authors:  Khushnooda Ramzan; Nouf S Al-Numair; Sarah Al-Ageel; Lina Elbaik; Nadia Sakati; Selwa A F Al-Hazzaa; Mohammed Al-Owain; Faiqa Imtiaz
Journal:  Genes (Basel)       Date:  2020-12-09       Impact factor: 4.096

8.  ILDR1 null mice, a model of human deafness DFNB42, show structural aberrations of tricellular tight junctions and degeneration of auditory hair cells.

Authors:  Eva L Morozko; Ayako Nishio; Neil J Ingham; Rashmi Chandra; Tracy Fitzgerald; Elisa Martelletti; Guntram Borck; Elizabeth Wilson; Gavin P Riordan; Philine Wangemann; Andrew Forge; Karen P Steel; Rodger A Liddle; Thomas B Friedman; Inna A Belyantseva
Journal:  Hum Mol Genet       Date:  2014-09-12       Impact factor: 6.150

9.  Diverse pattern of gap junction beta-2 and gap junction beta-4 genes mutations and lack of contribution of DFNB21, DFNB24, DFNB29, and DFNB42 loci in autosomal recessive nonsyndromic hearing loss patients in Hormozgan, Iran.

Authors:  Masoud Akbarzadeh Laleh; Marzieh Naseri; Ali Akbar Poursadegh Zonouzi; Ahmad Poursadegh Zonouzi; Marjan Masoudi; Najmeh Ahangari; Leila Shams; Azim Nejatizadeh
Journal:  J Res Med Sci       Date:  2017-08-16       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.